Ieq Capital LLC Sells 17,956 Shares of Corteva, Inc. (NYSE:CTVA)

Ieq Capital LLC lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 69.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,062 shares of the company's stock after selling 17,956 shares during the quarter. Ieq Capital LLC's holdings in Corteva were worth $459,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Hager Investment Management Services LLC purchased a new position in Corteva during the 4th quarter worth $27,000. Golden State Wealth Management LLC purchased a new position in shares of Corteva during the fourth quarter worth $32,000. First Financial Corp IN purchased a new stake in Corteva in the 4th quarter worth approximately $35,000. Albion Financial Group UT increased its stake in shares of Corteva by 112.6% in the 4th quarter. Albion Financial Group UT now owns 606 shares of the company's stock valued at $35,000 after purchasing an additional 321 shares in the last quarter. Finally, Brown Lisle Cummings Inc. increased its holdings in Corteva by 159.6% in the 4th quarter. Brown Lisle Cummings Inc. now owns 732 shares of the company's stock worth $42,000 after acquiring an additional 450 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares of the company's stock, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company's stock.

Corteva Trading Up 0.2 %

NYSE:CTVA traded up $0.14 on Friday, hitting $62.96. 3,509,625 shares of the stock were exchanged, compared to its average volume of 3,528,867. The stock has a fifty day moving average of $61.34 and a 200-day moving average of $59.28. The stock has a market cap of $43.16 billion, a PE ratio of 48.81, a PEG ratio of 1.68 and a beta of 0.78. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva announced that its Board of Directors has approved a stock repurchase plan on Tuesday, November 19th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 7.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its shares are undervalued.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.08%. The ex-dividend date of this dividend is Monday, March 3rd. Corteva's dividend payout ratio (DPR) is presently 52.71%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Wells Fargo & Company upped their target price on Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a report on Tuesday, January 28th. BNP Paribas upgraded shares of Corteva to a "hold" rating in a research note on Monday, February 10th. UBS Group cut their price target on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. KeyCorp lifted their price objective on shares of Corteva from $68.00 to $70.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Finally, Citigroup upped their target price on shares of Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, Corteva currently has a consensus rating of "Moderate Buy" and a consensus price target of $67.79.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.